Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000013

Chief Scientific Officer sold 7,763 shares at an average $117.57 ($912,703)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garfield Alastair Chief Scientific Officer 2026-08-13 Sale 10b5-1 −2,007 $116.11 $233,031 8,051 D: show line 1 in the form
Garfield Alastair Chief Scientific Officer 2026-08-13 Sale 10b5-1 −1,556 $117.08 $182,170 6,495 D: show line 2 in the form
Garfield Alastair Chief Scientific Officer 2026-08-13 Sale 10b5-1 −3,400 $118.28 $402,167 3,095 D: show line 3 in the form
Garfield Alastair Chief Scientific Officer 2026-08-13 Sale 10b5-1 −800 $119.17 $95,335 2,295 D: show line 4 in the form
Open-market sales · 7,763 sh · avg $117.57 · $912,703
Loading xslF345X06/form4.xml…